Vibrotactile Stimulation for Stroke Recovery
Trial Summary
What is the purpose of this trial?
Supplementing or augmenting sensory information to those who have lost proprioception after stroke could help improve functional control of the arm. Thirty subjects will be recruited to a single site to evaluate the ability of supplemental kinesthetic feedback (a form of vibrotactile stimulation) to improve motor function. Participants will be tested in performing reaching movements as well as more functional tasks such as simulated drinking from a glass
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using certain antibiotics or agents that affect neuromuscular function.
What data supports the effectiveness of the treatment Vibrotactile stimulation for stroke recovery?
Research shows that using mechanical vibration, similar to vibrotactile stimulation, can improve hand motor function in stroke survivors by enhancing sensory input. Additionally, motor rehabilitation programs that include tactile elements have been found to improve tactile sensation in individuals with chronic stroke, suggesting potential benefits for recovery.12345
Is vibrotactile stimulation safe for humans?
Research shows that using vibrotactile stimulation devices, like the TheraBracelet, is generally safe for stroke survivors, with only mild side effects such as worsened sensory scores in some cases. Most participants did not experience significant adverse effects, indicating that this type of stimulation is safe for prolonged use.678910
How is the treatment Vibrotactile Stimulation unique for stroke recovery?
Vibrotactile Stimulation (VTS) is unique because it uses mechanical vibrations to stimulate the affected limb, which can improve hand function and reduce muscle tightness in stroke survivors. Unlike traditional therapies, VTS can be delivered through a wearable device like the VTS Glove, making it suitable for both clinical and home use.147810
Eligibility Criteria
This trial is for stroke survivors with mild-to-moderate arm impairment, who can feel touch in the affected arm or thigh and have a minimal ability to extend their wrist. They must be at least 6 months post-stroke from an MCA event, able to consent and follow instructions, and have specific proprioceptive deficits. People with bleeding disorders, muscle diseases like ALS or myasthenia gravis, epilepsy, severe psychiatric conditions, pacemakers or significant heart issues cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Testing
Participants complete baseline tests of cognitive performance and sensorimotor impairment
Training
Participants undergo 20 sessions of training with supplemental kinesthetic feedback to improve motor control
Post-Training Assessment
Participants are re-tested on their capability to use a 3-DOF vibrotactile display for reach-to-grasp actions
Follow-up
Participants are monitored for safety and effectiveness after training
Treatment Details
Interventions
- Vibrotactile stimulation (Behavioral Intervention)
Vibrotactile stimulation is already approved in United States, European Union for the following indications:
- Rehabilitation of upper limb function in chronic stroke patients
- Relief of post-stroke spasticity
- Rehabilitation of upper limb function in chronic stroke patients
- Improvement of tactile perception and voluntary movement